[1]
Muñoz-Rangel, C.A. et al. 2015. Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie’s Disease. Urology Journal. 12, 2 (Apr. 2015), 2105–2110. DOI:https://doi.org/10.22037/uj.v12i2.2894.